{"id":{"repo_id":"mit","oai_identifier":"oai:dspace.mit.edu:1721.1/90220"},"canonical_url":"https://search.dev.ndltd.org/etd/mit/oai:dspace.mit.edu:1721.1/90220","repository":{"repo_id":"mit","name":"MIT","base_url":"https://dspace.mit.edu/oai/request"},"display":{"title":"Adaptive design of clinical trials : understanding the barriers to adoption","abstract":"There is great competition for clinical research funding. This is in part due to the National Institute of Health's reduced budget to support such initiatives. It has resulted in a growing trend for clinical research to use adaptive design models to accelerate clinical trials and at the same time reduce overall cost. Although such models have existed for several years, the pace of adoption remains slow, especially for early-stage clinical research. Through a review of relevant literature and interviews with industry experts, this thesis explores the barriers that inhibit the adoption of adaptive design of clinical trials. Reasons uncovered include: a lack of novel funding mechanisms, regulatory uncertainty, logistical difficulties, overly technical communications, a lack of collaboration among stakeholders, and an inability to recruit and retain patients. Then follows a series of possible solutions - some already functioning, others possible - for each of the barriers. This research found that unless efforts are devoted to addressing these underlying barriers, the widespread adoption of adaptive designs for clinical trials will not occur. The thesis concludes with recommendations and suggestions for future research.","abstract_html":"There is great competition for clinical research funding. This is in part due to the National Institute of Health's reduced budget to support such initiatives. It has resulted in a growing trend for clinical research to use adaptive design models to accelerate clinical trials and at the same time reduce overall cost. Although such models have existed for several years, the pace of adoption remains slow, especially for early-stage clinical research. Through a review of relevant literature and interviews with industry experts, this thesis explores the barriers that inhibit the adoption of adaptive design of clinical trials. Reasons uncovered include: a lack of novel funding mechanisms, regulatory uncertainty, logistical difficulties, overly technical communications, a lack of collaboration among stakeholders, and an inability to recruit and retain patients. Then follows a series of possible solutions - some already functioning, others possible - for each of the barriers. This research found that unless efforts are devoted to addressing these underlying barriers, the widespread adoption of adaptive designs for clinical trials will not occur. The thesis concludes with recommendations and suggestions for future research.","abstract_has_math":false,"creators":["Khalid, Ayesha N. (Ayesha Naz)"],"institution":"Massachusetts Institute of Technology","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Sloan School of Management.","school":null,"contributors":[],"advisors":["Andrew Lo."],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014","date_published":"2014","updated_at":"2026-07-22T22:22:28Z","subjects":["Sloan School of Management."],"languages":["eng"],"rights":["M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission."],"rights_urls":["http://dspace.mit.edu/handle/1721.1/7582"],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/1721.1/90220","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Andrew Lo."]},{"key":"dc:contributor.department","label":"Department","values":["Sloan School of Management."]},{"key":"dc:contributor.other","label":"Dc Contributor Other","values":["Sloan School of Management."]},{"key":"dc:creator","label":"Author","values":["Khalid, Ayesha N. (Ayesha Naz)"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-09-19T21:46:52Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-09-19T21:46:52Z"]},{"key":"dc:date.issued","label":"Date","values":["2014"]},{"key":"dc:publisher","label":"Institution","values":["Massachusetts Institute of Technology"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Sloan School of Management."]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission."]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://dspace.mit.edu/handle/1721.1/7582"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/1721.1/90220"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2014.","Cataloged from PDF version of thesis.","Includes bibliographical references (pages 69-72)."]},{"key":"dc:description.abstract","label":"Abstract","values":["There is great competition for clinical research funding. This is in part due to the National Institute of Health's reduced budget to support such initiatives. It has resulted in a growing trend for clinical research to use adaptive design models to accelerate clinical trials and at the same time reduce overall cost. Although such models have existed for several years, the pace of adoption remains slow, especially for early-stage clinical research. Through a review of relevant literature and interviews with industry experts, this thesis explores the barriers that inhibit the adoption of adaptive design of clinical trials. Reasons uncovered include: a lack of novel funding mechanisms, regulatory uncertainty, logistical difficulties, overly technical communications, a lack of collaboration among stakeholders, and an inability to recruit and retain patients. Then follows a series of possible solutions - some already functioning, others possible - for each of the barriers. This research found that unless efforts are devoted to addressing these underlying barriers, the widespread adoption of adaptive designs for clinical trials will not occur. The thesis concludes with recommendations and suggestions for future research."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["M.B.A."]},{"key":"dc:title","label":"Title","values":["Adaptive design of clinical trials : understanding the barriers to adoption"]}]}],"canonical_facts":{"dc:contributor.advisor":["Andrew Lo."],"dc:contributor.department":["Sloan School of Management."],"dc:contributor.other":["Sloan School of Management."],"dc:creator":["Khalid, Ayesha N. (Ayesha Naz)"],"dc:date.accessioned":["2014-09-19T21:46:52Z"],"dc:date.available":["2014-09-19T21:46:52Z"],"dc:date.issued":["2014"],"dc:description":["Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2014.","Cataloged from PDF version of thesis.","Includes bibliographical references (pages 69-72)."],"dc:description.abstract":["There is great competition for clinical research funding. This is in part due to the National Institute of Health's reduced budget to support such initiatives. It has resulted in a growing trend for clinical research to use adaptive design models to accelerate clinical trials and at the same time reduce overall cost. Although such models have existed for several years, the pace of adoption remains slow, especially for early-stage clinical research. Through a review of relevant literature and interviews with industry experts, this thesis explores the barriers that inhibit the adoption of adaptive design of clinical trials. Reasons uncovered include: a lack of novel funding mechanisms, regulatory uncertainty, logistical difficulties, overly technical communications, a lack of collaboration among stakeholders, and an inability to recruit and retain patients. Then follows a series of possible solutions - some already functioning, others possible - for each of the barriers. This research found that unless efforts are devoted to addressing these underlying barriers, the widespread adoption of adaptive designs for clinical trials will not occur. The thesis concludes with recommendations and suggestions for future research."],"dc:description.degree":["M.B.A."],"dc:identifier.uri":["http://hdl.handle.net/1721.1/90220"],"dc:language.iso":["eng"],"dc:publisher":["Massachusetts Institute of Technology"],"dc:rights":["M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission."],"dc:rights.uri":["http://dspace.mit.edu/handle/1721.1/7582"],"dc:subject":["Sloan School of Management."],"dc:title":["Adaptive design of clinical trials : understanding the barriers to adoption"],"dc:type":["Thesis"]},"updated_at":"2026-07-22T22:22:28Z"}